PLEASANTON, Calif., January 23, 2018—CooperVision, Inc. has announced the creation of its Specialty Eye Care business unit, designed to accelerate eye care professionals’ access to innovative products that help improve the way people see each day. Dr. Juan Carlos Aragon has been named President of the business, effectively immediately.
The new Specialty Eye Care business currently encompasses Soflex, Procornea and Paragon Vision Sciences, which design and manufacture highly-specialized contact lenses for the management of myopia and other indications. These organizations will continue to operate independently, yet share technical, clinical and commercial knowledge while benefitting from CooperVision’s global presence and infrastructure.
An industry veteran, Dr. Aragon has three decades of experience in general management, professional services, sales, marketing, and business development. Since joining CooperVision in 2000, and has held senior roles in the Americas, Europe and Asia Pacific. Most recently, he was responsible for overseeing the company’s Southern & Central European Commercial Operations. He previously served in leadership positions with Ocular Sciences, CIBA Vision, and Bausch + Lomb.
“The extensive management and contact lenses technical experience that Juan Carlos brings to the role will be essential to developing even stronger partnerships and opportunities for customers worldwide,” said Andrew Sedgwick, Executive Vice President, CooperVision. “He and his team will help expand the availability and adoption of advanced specialty products, complementing the wide-range of innovative contact lenses developed by CooperVision.”
Dr. Aragon graduated as an optometrist from the Superior School of Medicine of the National Polytechnic Institute in Mexico City. In addition to his professional responsibilities, he volunteers as Chairman of the Board of Directors of Optometry Giving Sight, and serves as a Trustee of the International Agency for the Prevention of Blindness and Vision Aid Overseas.
# # #
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, Calif., Cooper has more than 11,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Mike McDougall, APR, Fellow PRSA
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-434-2150